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ABSTRACT- This paper describes the synthesis of a β-cyclodextrin (β-CyD) derivative conjugated with a 
C,C-glucopyranoside containing a benzene unit. Its doxorubicin-inclusion ability and structure are also discussed. 
SPR analysis revealed that the β-CyD conjugate had a high inclusion association value of 3.8 × 106 M−1 for 
immobilized doxorubicin. NMR structural analysis suggested that its high doxorubicin-inclusion ability was due to 
the formation of the inclusion complex as a result of the π–π stacking interaction between the benzene ring of the 
conjugate and the A ring of doxorubicin. 
 
1. Introduction 
Cyclodextrin (CyD) derivatives conjugated with sugar moieties have both the drug-inclusion ability of CyDs and 
the cell-recognition ability of sugar moieties. As a result, they are expected to carry drug molecules to targeted cells. 
Control of the drug-inclusion and release abilities of CyDs is of great importance in the development of 
drug-carrying molecules containing CyD.1 
 We recently synthesized several β-CyDs conjugated with a sugar moiety.2 These β-CyD conjugates were 
characterized by the benzene ring unit present in the spacer between the sugar moiety and the β-CyD unit. We 
revealed some inclusion properties and specific structures of the CyD-sugar conjugates. SPR assays indicated that 
they had remarkably high inclusion association constants (Ka = 105–106 M-1 level) for immobilized doxorubicin 
(Dox, anticancer agent). These Ka values were 100–1000 times higher than those of ordinary β-CyD. We then 
attempted to elucidate their excellent Dox-inclusion abilities through NMR structural analyses, which suggested 
that the benzene unit in the β-CyD conjugates formed specific conformations, as shown in Figure 1. The NMR 
spectra of CyD conjugates only (without Dox) indicated that they had a “closed can structure,” where the primary 
side of β-CyD was capped by the benzene unit. This conformation of the benzene unit increased the hydrophobicity 
of the CyD cavity and promoted the inclusion of Dox into the cavity. Conversely, the NMR spectra of both the 
β-CyD conjugates and Dox indicated that they had an “open can structure,” where the benzene unit was parallel to 
the CyD cavity. This specific conformation of the benzene unit caused a π–π stacking interaction between the 
benzene unit of the CyD conjugate and the A ring of Dox, as well as strengthened the Dox inclusion complexation.3 
Thus, the benzene unit of the β-CyD conjugates has serious influence on Dox inclusion. 
 
 
 
 
 
 
 
Figure 1. Specific conformations of the benzene ring of our prepared sugar-β-CyD conjugates. 
 
In addition, SPR assays revealed that the sugar moieties of the β-CyD conjugates bound to the sugar-binding 
proteins (lectins) with appropriate binding affinities. Therefore, these β-CyD conjugates are promising 
Dox-carrying molecules. 
Our studies on glycosidation reactions enabled successful development of a synthetic method for preparing 
C,C-glycopyranosides, which are expected to become a new type of artificial sugar.4 We then decided to design a 
new Dox-carrying molecule using a C,C-glycopyranoside. Figure 2 shows our newly designed β-CyD derivative 
conjugated with a C,C-glucopyranoside (1). β-CyD conjugate 1 is structurally unique in that the benzene unit is at 
the end of the spacer, placing the artificial sugar moiety between the benzene unit and the β-CyD unit. We 
predicted that this structure would make the spacer more flexible, enabling easy formation of the “closed can 
structure,” which could smoothly convert to the “open can structure” upon incorporation of Dox. We were also 
interested in the binding of the artificial sugar moiety to lectin (Concanavalin A, Con A). 
This paper describes the synthesis and evaluation of 1 as a Dox-carrying molecule. The Dox-inclusion ability 
and the lectin binding affinity of 1 were investigated through SPR assays. The behavior of the benzene unit of 1 
was elucidated through NMR spectral analysis. 
 
 
      
 
 
Figure 2. Newly designed β-CyD conjugate 1. 
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2. Results and discussion 
2.1. Synthesis of β-CyD conjugate 1 
Scheme 1 shows the synthetic procedure for the formation of 1 from 
1-α-allyl-1-β-benzyl-1-deoxy-D-glucopyranoside (2)4 and mono-6-amino-6-deoxy-β-CyD. Ozonization of 2 at 
−78 °C followed by reduction with triphenylphosphine gave aldehyde 3. Subsequent oxidation of 3 using NaClO2 
and NaH2PO4 in the presence of 2-methyl-2-butene afforded the corresponding carboxylic acid (4). The coupling 
reaction of 4 with mono-6-amino-6-deoxy-β-CyD using dimethylphosphinothioyl chloride and 
diisopropylethylamine (DIEA) in DMF afforded 1. 
 
 
 
 
 
Scheme 1. Preparation of 1: (a) −78 °C, O3, CH2Cl2, 10 min, then Ph3P, −78 °C→RT, 2h, 97%; (b) NaClO2, 
NaH2PO4, 2-methyl-2-butene, t-BuOH–H2O, 24 h, 96%; (c) Me2P(S)Cl, DIEA, DMF, 40 min, then 
mono-6-amino-6-deoxy-β-CyD, 24 h; (d) Pd(OH)2, H2, DMF, 58%. 
 
2.2. Evaluation of 1 through SPR assays 
2.2.1.  Dox-inclusion abil i ty of 1  
Dox was immobilized on the sensor cuvette of the SPR optical biosensor and measurement using 1 was 
conducted under the same conditions as previously reported.5 The amount of immobilized Dox was 0.167 ng/mm2. 
Figure 3 shows the kinetic linear plot of 1. The association rate constant (ka) and dissociation rate constant (kd) of 1 
for immobilized Dox were 2.4 × 104 M−1s−1 and 6.4 × 10−3 s−1, respectively, and the inclusion association (Ka), 
calculated by the relation of Ka= ka/kd, was 3.8 × 106 M−1. These values of 1 were in close agreement with those of 
our previously prepared sugar-conjugated β-CyD derivatives involving a benzene unit,6 whose Ka values were 
generally 103 times higher than those of ordinary β-CyD derivatives.7 Thus, we found that conjugate 1 had the 
excellent Dox-inclusion ability that we expected. This suggested that the benzene unit of 1 had a similar major 
influence on the improvement of its Dox-inclusion ability. 
 
2.2.2.  Binding abil i ty of 1  to immobil ized Con A 
 Con A was immobilized on the sensor cuvette of the SPR optical biosensor and measurement using 1 was 
conducted under the same conditions as previously reported.5 The amount of immobilized Con A was 2.52 ng/mm2. 
Figure 4 shows the kinetic linear plot of 1. The ka, kd, and Ka of 1 for immobilized Con A were 8.0 × 102 M−1s−1, 
2.7 × 10−3 s−1, and 3.0 × 105 M−1, respectively. The reported Ka value of PNP α-D-mannopyranoside for Con A is 
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2.0 × 105 M−1, hence the Ka value of 1 is in close agreement.8 Thus, we found that the C,C-glucopyranoside moiety 
of 1 was recognized by Con A. 
 
 
 
 
  
 
 
 
Figure 3. Kinetic linear plot of 1 for immobilized Dox. 
 
 
Figure 4. Kinetic linear plot of 1 for immobilized Con A. 
 
 
2.3.  Structures of 1 and the 1-Dox inclusion complex 
2.3.1.  1H NMR assignment of 1  and the 1 -Dox inclusion complex 
Figure 5 indicates the 1H NMR spectra of 1, Dox, and the mixed sample of 1 and DXR (1:1) in D2O at 25 °C. 
Assignment of the 1H NMR chemical shifts was determined by one- and two-dimensional NMR spectroscopic 
techniques, including 1H–1H COSY, HSQC, HOHAHA, and HMBC (data not shown). Table 1 lists these 
assignments. 
2.3.2.  S tructure of conjugate 1  
In Figure 5, the 1H NMR spectrum of 1 shows that the peaks for the Ha, Hb, and Hc protons of the benzene ring 
(identified in Figure 5 (iv)) are broad. This suggests that the benzene ring is influenced by CyD.  
Figure 6 presents the ROESY spectrum of 1 in D2O at 25 °C. Some long-range ROE interactions were observed. 
The Hb proton of the benzene ring had four ROE signals (a) with H6 protons (3.63, 3.71, 3.81, and 3.89 ppm) of 
CyD with similar intensities. 1H–1H COSY revealed that these four H6 protons bound with C6 carbons of three 
different glucoses of CyD. Considering the observations together with the molecular sizes of the benzene ring and 
β-CyD, it is inevitable that both of the two Hb protons of the benzene ring are involved in the ROEs. The Hc proton 
of the benzene ring also had an ROE interaction (c) with H6 of CyD. It was thus confirmed that three protons (two 
Hb protons and one Hc proton) of the flat benzene ring exist near the H6 protons of CyD. This means that the 
benzene ring lies over the primary side of CyD. In other words, the primary side of CyD is capped by the benzene 
ring and 1 forms the “closed can structure” as shown in Figure 7 [A]. In addition, two ROE signals (b and d) were 
observed. The signals indicate that one Hb proton and one Hc proton of the benzene ring simultaneously exist near 
H5 of CyD. It suggests the plane of the benzene ring inclines to the horizontal face of CyD. 
The ROE signal (e) between the Hc proton of the benzene ring and the Ha proton at C9’ was observed. This 
means that the plane of the benzene ring exists nearly parallel to the C9’–Ha9’ axis and the coplanar conformation 
is formed.9 The ROE signal (f) between the Hb proton at C9’ and the H4’ proton was observed. These observations 
show that the structure of the unit from the sugar moiety to the benzene ring is conformationally fixed. In addition, 
both the Ha9’ and the Hb9’ had the ROE interactions (g and h) with the same H6 proton (3.76 ppm) of CyD. This 
observation determined how the unit from the sugar moiety to the benzene ring exists above CyD. It is also the 
evidence that the benzene ring lies over the primary side of CyD. 
The molecular structure of 1 suggested by all the above-mentioned ROEs can be summarized as follows: the 
primary side of CyD is capped by the benzene ring and the “closed can structure” is formed as shown in Figure 7 
[A]. The sugar moiety is located above the benzene ring. The tilt of the benzene ring is estimated to be about 30 
degrees to the horizontal face of CyD. 
2.3.3.  S tructure of the 1–Dox inclusion complex 
Several reports revealed that Dox formed the inclusion complex with β-CyD only in a 1 : 1 stoichiometry and the 
A ring of Dox was included through the secondary side of β-CyD (A-up orientation).10 We also used the mixed 
sample of 1 and Dox (1:1) in the following NMR experiments.  
Figure 5 shows the 1H NMR spectrum of the mixed sample in D2O at 25 °C. Shifting and broadening of some 
signals were observed. The protons (H4 and H14) on the D ring in Dox shifted significantly downfield 0.23-0.25. 
The protons (Ha3, Hb3, Ha13, and Hb13) on the D ring shifted upfield 0.02-0.07 ppm. The protons (He and Hd) on 
the A ring in Dox shifted upfield 0.02–0.07 ppm, accompanied by broadening. The proton signals (Ha and Hb) on 
the benzene ring of 1 also moved upfield 0.03–0.04 ppm. These upfield shifts support the parallel stacking 
configuration between the benzene ring of 1 and the benzene unit of Dox. 
Figure 9 shows the NOESY spectrum of the mixed sample. Several long-range NOE interactions were observed. 
The He proton on the A ring in Dox had an NOE interaction (i) with H6 of CyD. The NOE interactions (j and m) 
between the H5” proton and the H3 proton were observed, while the NOESY spectrum of only Dox indicated the 
NOE interaction between the H1” proton and the H3 proton (data not shown). These observations mean that the 
inclusion of Dox into 1 rotated the glycoside bond of the amino sugar of Dox. The significant downshift of the H14 
proton of Dox mentioned above would be caused by the conformation change of Dox influenced by the amino 
sugar. These NOE observations (i, j and m) tell that Dox forms an inclusion complex with 1 with A-up orientation 
and the A ring of Dox exists close to H6 of CyD.  
The Hb proton of the benzene ring of 1 had two NOE interactions (a) with H6 of CyD; one showed a strong 
signal intensity, and the other showed a weak signal intensity. This Hb proton had an NOE interaction (b) with H5 
of CyD with a strong signal intensity, too. A quite similar signal tendency was observed in the NOE interactions (c 
and d) between the Hc proton of the benzene ring and H6 or H5 of CyD. Considering the existence of the A ring of 
Dox near H6 of CyD, the “closed can structure” disappeared upon inclusion of Dox. It was strongly suggested that 
one Hb proton and one Hc proton of the benzene ring were concerned with the above NOE interactions (a, b, c and 
d). 
The Hc proton of the benzene ring of 1 had strong NOE interactions (e and f) with both the Ha and Hb protons 
on 9’ of 1 with similar intensities. The weak NOE interactions (k and l) between the Hb proton of the benzene ring 
and those on 9’ of 1 were observed with similar intensities. These observations suggest that the plane of the 
benzene ring of 1 exists nearly parallel to the C3’–C9’ axis, based on the formation of a stable coplanar 
conformation.9 Therefore, the C9’–C10’ axis of 1 rotates by 60 degrees upon Dox inclusion. The proton on 4’ of 1 
had NOE interactions (g and h) with both the Ha and Hb protons on 9’ with similar signal intensities. This 
observation shows that the C3’–C9’ axis of 1 rotates by 120 degrees upon Dox inclusion. In addition, both the Ha9’ 
and the Hb9’ had the NOE interactions (expansion data not shown) with the same H6 proton of CyD. It means that 
C9’ is the center of the 120 degrees rotation. 
The change from the “closed can structure” to the “open can structure” of 1 can be explained logically by the 
above-mentioned rotations. In order to discuss stepwise the rotations of the C9’–C10’ axis and the C3’–C9’ axis, 
Newman projections are shown in Figure 8. Figure 8 [A-1] and [A-2] showed the Newman projections viewed 
along the C3’–C9’ axis or the C9’–C10’ axis of the structure Figure 7 [A] of 1, respectively. The 60 degrees 
rotation of the C9’–C10’ axis of [A-1] makes the benzene ring vertical, as shown in [A’-1]. The following 120 
degrees rotation of the C3’–C9’ axis of the structure [A’-1], keeping the benzene ring vertical, moves it aside in the 
CyD cavity, and also moves the sugar unit away from the position above the CyD cavity, as shown in [B-1] and 
[B-2]. Thus, these rotations make the space which is necessary to include the Dox molecule and to stack the two 
aromatic rings parallel to each other (π-π parallel stacking) in the CyD cavity. Recently, Swiech et al., reported the 
Dox-β-CyD complexes suggesting high possibility of strong π-π parallel stacking interactions between the A ring 
of Dox and the aromatic phenyl rings in the side chains of β-CyD based on molecular modeling.11 Their reports 
also support our proposed “open can structure”.   
 
 
 
 
 
Table 1. 1H NMR chemical shifts of 1, Dox, and a mixed sample of 1 and Dox (1:1) 
Compound 
Proton 
Chemical shift Chemical shift 
change 
Upfield (+)/ppm 
Downfield (-)/ppm 
Single substance sample 
(1 or Dox) 
Mixed sample 
(1 and Dox) 
1 CyD unit H1 4.87 [d, 2.8], 4.89, 4.89, 4.90, 4.91, 
4.91, 4.99 [d, 2.8] 
4.88 [d, 3.5], 4.89, 4.89, 4.90, 4.91, 
4.91, 4.94 
 
H2 3.40, 3.41, 3.51, 3.52, 3.55, 3.57, 3.59 3.40, 3.41, 3.50, 3.51, 3.51, 3.55, 3.55  
H3 3.82, 3.82, 3.84, 3.88, 3.88, 3.90, 3.94 3.78, 3.78, 3.82, 3.82, 3.84, 3.88, 3.90  
H4 3.20 [t, 9.0], 3.46, 3.48, 3.49, 3.53, 
3.54, 3.57 
3.21 [t, 9.0], 3.44, 3.44, 3.46, 3.48, 
3.48, 3.49 
 
H5 3.56, 3.61, 3.68, 3.68, 3.69, 3.69, 3.73 3.56, 3.65, 3.67, 3.68, 3.69, 3.70, 3.71  
H6 3.63, 3.64, 3.67, 3.68, 3.69, 3.71, 
3.75, 3.76, 3.77, 3.78, 3.785, 3.81, 
3.82, 3.89 
3.59–3.61, 3.73-3.76, 3.76–3.81  
C,C-Glucosyl 
unit 
Ha2’ 2.54 [d, 15.8] 2.54 [d, 15.9]  
Hb2’ 2.60 [d, 15.8] 2.62 [d, 15.2] −0.02 
H4’ 3.08 [d, 9.6] 3.07 [d, 9.6]  
H5’ 3.45 3.42 +0.03 
H6’ 3.47 3.50 −0.03 
H7’ 3.76 3.75  
Ha8’ 2.89 [m] 2.90 [m]  
Hb8’ 3.02 [m] 3.00 [m] +0.02 
Ha 7.19 [bs] 7.15 [m] +0.04 
Hb 7.21 [bs] 7.18 [t, 6.9] +0.03 
Hc 7.15 [bs] 7.15  
Ha9’ 2.95 [d, 14.5] 2.93 [d, 14.5]  
Hb9’ 2.70 [d, 14.4] 2.71 [d, 14.5]  
Dox Anthracycline 
unit 
Ha3 1.91 [m] 1.89 +0.02 
Hb3 2.13 [d, 14.4] 2.09 [d, 11.7] +0.04 
H4 4.74 [d, 4.1] 4.97 [d, 3.5] −0.23 
OCH3 3.74 [s] 3.73 [s]  
Hd 7.17 [d, 7.6] 7.10 [m] +0.07 
He 7.47 [t, 7.6] 7.45 [bs] +0.02 
Hf 7.19 [d, 8.2] 7.20 −0.01 
Ha13 2.45 [d, 17.9] 2.38 [m] +0.07 
Hb13 2.78 [d, 17.2] 2.75 [m] +0.03 
H14 4.70 [d, 4.1] 4.95 −0.25 
Sugar unit H1” 5.33 [s] 5.30 [bs] +0.03 
H2” 1.88–1.89 1.85–1.87 +0.02–0.03 
H3” 3.70 [m] 3.61 +0.09 
H4” 3.60 3.61 [m]  
H5” 4.12 [m] 4.09 [m] +0.03 
H6” 1.19 [d, 6.9] 1.18 [d, 6.9]  
 Figure 7. Postulated structures of 1 and its Dox complex. 
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Figure 8. Newman projections. 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
(i)  1H NMR spectra                              (ii) Expansion of (a) 
 
 
 
 
 
 
 
 
 
 
 
 
(iii) Expansion of (b)                             (iv) Expansion of (c) 
Figure 5. 1H NMR spectra of 1, Dox, and mixed 1-Dox (1:1). (D2O, 25 °C, 16 scans, 1: 2 mM, Dox: 2 mM). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 (i)   ROESY NMR spectrum                                                                                        
(ii)  
 
Expansion of (a) 
 
 
 
 
 
 
 
 
 
 
 
 
(iii) Expansion of (b)                                 (iv) Expansion of (c)                                                                                                                                                                                                        
Figure 6. ROESY NMR spectrum of 1. (D2O, 25 °C, mixing time: 1000 ms, 32 scans, 2 mM) 
 
 
 
 
 
 
 
 
 
                                                                                      
                                                                                                             
 
 
 
 
 
 
 
 
(i) NOESY NMR spectrum                         (ii) Expansion of (a) 
 
 
 
 
 
 
 
 
 
 
 
(iii) Expansion of (b)                                           (iv) Expansion of (c)                                                                            
Figure 9. NOESY NMR spectrum of mixed 1-Dox (1:1). (D2O, 25 °C, mixing time: 500 ms, 64 scans, 1: 2 mM, 
Dox: 2 mM) 
 
 
3. Conclusion 
We successfully synthesized a β-CyD derivative conjugated with C,C-glucopyranoside (1). SPR analyses 
showed that the CyD conjugate demonstrated high Dox-inclusion ability and was able to bind to Con A with a 
typical inclusion association constant. NMR structural analyses revealed that the conjugate formed the “closed can 
structure,” which converted to the “open can structure” upon incorporation of Dox. We expect this CyD conjugate 
to have potential use as a Dox-carrying molecule. 
 
 
4. Experimental 
4.1. General 
1H NMR (600 MHz) and 13C NMR (150 MHz) spectra were recorded on a JEOL ECA-600 spectrometer. The 
NOESY experiment was performed at 25 °C with a mixing time of 500 ms. The ROESY experiment was 
performed at 25 °C with a mixing time of 1000 ms. The measuring conditions for the 2D spectra were as follows: 
spectral width 4500 Hz; data size 1024 (F2)/ 486 (F1); relaxation delay 1.5 s. Melting points were measured with a 
BÜCHI Melting Point B-545 and uncorrected. Optical rotations were recorded on a JASCO DIP-360 digital 
polarimeter. HRMS data were obtained using a Mariner spectrometer (PerSeptive Biosystems Inc.). 
MALDI-TOF-MS data were recorded using a JMS-S3000 spectrometer. Preparative TLC was performed on Merck 
silica gel 60GF254. Column chromatography was conducted using silica gel 60N (40–50 μm, Kanto Chemical Co., 
Inc.) All anhydrous solvents were purified according to standard methods. 
4.1.1.  3,7-Anhydro-3-C-benzyl-4,5,6,8-te tra-O-benzyl-2-deoxy-D-glycero-D-ido-octose (3)  
Ozone was bubbled through a solution of 2 (104.4 mg, 0.2 mmol) in CH2Cl2 (5 mL) while stirring at −78 °C for 
10 min. After triphenylphosphine (129.6 mg, 0.5 mmol) was added at −78 °C, the reaction temperature was raised 
to room temperature and the reaction mixture was stirred for 2 h. The solvent was then evaporated under reduced 
pressure. The crude product was purified by preparative TLC (hexane:ethyl acetate = 4:1) to afford 3 (99.8 mg, 
97%) as a colorless oil.  [α]23D  = +22
o (c 1.4, CHCl3). 1H NMR (600 MHz, CDCl3): δ 2.68 (1H, dd, J = 2.5 Hz, J = 
15.4 Hz, Ha2), 2.84 (1H, dd, J = 3.7 Hz, J = 15.4 Hz, Hb2), 3.01 (1H, d, J = 14.2 Hz, Hb9), 3.19 (1H, d, J = 14.1 
Hz, Ha9), 3.40 (1H, d, J = 9.5 Hz, H4), 3.58 (1H, t, J = 9.6 Hz, H6), 3.69 (2H, m, H6, Ha8), 3.74 (1H, dd, J = 3.4 
Hz, J = 10.3 Hz, Hb8), 3.85 (1H, t, J = 9.6 Hz, H5), 4.52-4.91 (8H, m, CH2Ph), 9,62 (1H, s, H1); 13C NMR (150 
MHz, CDCl3): δ 43.9 (C-9), 44.5 (C-2), 69.1 (C-8), 72.8 (C-7), 75.0 (CH2Ph), 75.0 (CH2Ph), 75.6 (CH2Ph), 76.7 
(CH2Ph), 78.5 (C-6), 79.3 (C-3), 81.6 (C-4), 84.3 (C-5), 200.4 (C-1). HRMS (ESI): m/z calcd for C43H44O6•Na+: 
679.3036; found 679.3045. 
4.1.2.  3,7-Anhydro-3-C-benzyl-4,5,6,8-te tra-O-benzyl-2-deoxy-D-glycero-D-ido-octonic Acid 
(4)  
To a solution of 3 (64.0 mg, 0.1 mmol) in t-butanol (3 mL) and H2O (1 mL) was added NaClO2 (38.2 mg, 0.4 
mmol), NaH2PO4 (27.2 mg, 0.2 mmol), and 2-methyl-2-butene (46.4 μL, 0.4 mmol). After the reaction mixture was 
stirred for 24 h, the reaction was quenched by adding 2 M HCl (1 mL) and water (5 mL). After the reaction mixture 
was extracted with CH2Cl2 (three times), the combined organic solvent was dried over anhydrous Na2SO4. The 
organic solvent was filtered and evaporated under reduced pressure. The crude product was purified by preparative 
TLC (hexane:ethyl acetate = 1:1) to afford 4 (64.2 mg, 96%) as a colorless oil.  [α]23D  = +34
o (c 1.2, CHCl3). 1H 
NMR (600 MHz, CDCl3): δ 2.84 (1H, d, J = 13.7 Hz, Ha2), 2.92 (1H, d, J = 16.4 Hz, Hb2), 3.01 (1H, d, J = 15.1 
Hz, Hb9), 3.42 (1H, d, J = 15.1 Hz, Ha9), 3.41 (1H, d, J = 6.8 Hz, H4), 3.53 (1H, t, J = 9.6 Hz, H6), 3.73-3.77 (2H, 
m, H8), 3.85 (1H, t, J = 9.6 Hz, H5), 3.85-3.88 (1H, m, H7), 4.50-4.88 (8H, m, CH2Ph); 13C NMR (150 MHz, 
CDCl3): δ 36.6 (C-2), 42.5 (C-9), 69.0 (C-8), 72.9 (C-7), 73.2 (CH2Ph), 74.7 (CH2Ph), 75.0 (CH2Ph), 75.6 (CH2Ph), 
78.4 (C-6), 79.3 (C-4), 80.1 (C-5), 84.1 (C-3), 175.1 (C-1). HRMS (ESI): m/z calcd for C43H44O7•Na+: 695.2985; 
found 695.3037. 
4.1.3.  6I-(3,7-Anhydro-3-C-benzyl-2-deoxy-D-glycero-D-ido-octonamido)-6 I-deoxycyclomalto
heptaose (1)  
To a solution of 4 (45.2 mg, 0.07 mmol) in DMF (2 mL) was added dimethylphosphinothioyl chloride (8.6 mg, 
0.06 mmol) and DIEA (11.7 μL, 0.07 mmol). After the reaction mixture was stirred for 40 min, 
mono-6-amino-6-deoxy-β-CyD (85.2 mg, 0.08 mmol) in DMF (1 mL) was added. After the reaction mixture was 
stirred for 24 h, the solvent was evaporated under reduced pressure. The resulting reaction mixture was washed 
with diethyl ether (eight times) and dissolved in DMF (15 mL). Palladium hydroxide (45.7 mg, 0.3 mmol) was 
added to the solution and hydrogen was bubbled through for 24 h. After the solvent was filtered and evaporated 
under reduced pressure, the crude product was isolated by adsorption on HP 20 (DIAION), followed by elution 
with methanol to afford 1 (55.2 mg, 58%) as white crystals. Mp 264-266 °C. [α]23D  = +126
o (c 0.4, MeOH). 13C 
NMR (150 MHz, D2O): δ 12.8, 22.8, 36.2, 41.3, 43.2, 43.2, 55.0, 60.6, 60.6, 60.8, 62.7, 71.2, 71.7, 72.4, 72.6, 72.6, 
72.8, 73.6, 73.8, 74.5, 74.6, 78.7, 80.1, 81.2, 81.3, 81.3, 81.6, 81.7, 84.3, 102.2, 102.5, 102.5, 102.6, 127.5, 128.0, 
128.4, 128.8, 131.0, 136.4, 172.9. MALDI-TOF MS: m/z calcd for C57H89NO40•Na+: 1450.4859; found. 1450.4899. 
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